glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Frontiers Clinical Focus on GLP-1 Agonists

Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake

Lisa J Moran, Monash Centre for Health Research and Implementation, Monash University and Monash Health, Melbourne, Victoria, Australia

These pharmacological agents exhibit beneficial effects on glycemic regulation, weight management, and cardiovascular outcomes, thereby establishing their essential roles in contemporary diabetes management [3-5]

doi: 10.1016/S0140-6736(19)31149-3

"In the short term, we have this temporary program, and then no clear path forward yet as to what will happen at the end of 2027," she said